---
type: "Lives"
title: "Abbott Laboratories (ABT.US) Q3 2025 Earnings Conference Call"
locale: "en"
url: "https://longbridge.com/en/lives/335223.md"
parent: "https://longbridge.com/en/lives.md"
status: "✅ Ended"
datetime: "2025-10-15T13:00:00Z"
locales:
  - [en](https://longbridge.com/en/lives/335223.md)
  - [zh-CN](https://longbridge.com/zh-CN/lives/335223.md)
  - [zh-HK](https://longbridge.com/zh-HK/lives/335223.md)
generator: "portal-rs"
---

# Abbott Laboratories (ABT.US) Q3 2025 Earnings Conference Call

> ✅ Ended | Earnings Call

- **Datetime**: 2025-10-15T13:00:00Z
- **Duration**: 3850s
- **Host**: Live Assistant
- **112 viewers**
- **Replay**: Available
- **Replay URL**: [Audio](https://tts.pbkrs.com/live/roadshow/file/video/roadshow/2025/10/audio/4830146.mp3?remote_token=BUvYpycygAZhzNAt)

雅培公司 (ABT.US) 2025 年第三季度业绩电话会

## Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related Filings

### Abbott Laboratories | (10-Q) Basic quarterly filing — 2025-10-29T16:22:25-04:00

- [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/abt-20250930.htm)
- [EX-31.1](https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/q3202510qex311.htm)
- [EX-31.2](https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/q3202510qex312.htm)
- [EX-32.1](https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/q3202510qex321.htm)
- [EX-32.2](https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/q3202510qex322.htm)

### Abbott Laboratories | (8-K) Current Report — 2025-10-15T07:33:48-04:00

- [8-K](https://www.sec.gov/Archives/edgar/data/1800/000162828025045049/abt-20251015.htm)
- [EX-99.1](https://www.sec.gov/Archives/edgar/data/1800/000162828025045049/abt-2025q3xexhibitx991.htm)

## Meeting Summary




















































































































































































































































































































---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**